Phase 2 study of an HIV-1 canarypox vaccine (vCP1452) alone and in combination with rgp120: negative results fail to trigger a phase 3 correlates trial.

Source:http://linkedlifedata.com/resource/pubmed/id/17106277

J. Acquir. Immune Defic. Syndr. 2007 Feb 1 44 2 203-12

Download in:

View as

Triples

General Info

PMID
17106277